Asthma vs. COPD: the differences that actually change treatment

Asthma and COPD both narrow the airways and both get treated with inhalers, which is where the resemblance mostly ends. Asthma's airway narrowing is classically reversible — with a bronchodilator, function measured on spirometry returns close to normal between episodes — while COPD's airflow limitation is only partially reversible at best, reflecting genuine, largely permanent structural damage to lung tissue and airways rather than an episodic spasm that resolves.

The onset pattern differs too: asthma frequently starts in childhood and is closely tied to allergic triggers, while COPD is overwhelmingly a disease of adults with a long smoking history (or, less commonly, significant occupational or biomass smoke exposure), typically not showing up clinically until well into middle age or later. Someone can have both — 'asthma-COPD overlap' is a recognized clinical category — and that combination tends to behave more like COPD in terms of long-term trajectory even when asthma triggered the initial diagnosis decades earlier.

The oxygen question tracks this distinction closely. Asthma, even poorly controlled asthma, rarely progresses to a point where supplemental oxygen becomes part of long-term management outside of an acute attack requiring emergency treatment. COPD, by contrast, is one of the leading reasons people end up on home oxygen at all, precisely because the damage is structural and progressive rather than an inflammatory episode that resolves with the right inhaler.

If there's one practical takeaway for someone recently diagnosed with either: the treatment plan that works depends entirely on which one you actually have, and a diagnosis based on symptoms alone — wheeze, breathlessness — without spirometry confirming the reversibility pattern is worth revisiting with a pulmonologist before assuming either label is settled.